Creating a Category: Architecting Bioregeneration
Premise
So they had cracked the code on a true tissue regeneration and were in the early stages of transitioning from scientific development into a publicly traded, commercially viable medical technology business. Building toward market entry and public filing, the company needed to differentiate in a space loaded with buzzwords, false claims and overall confusion around regenerative medicine.
Precedent
The novel extracellular matrix (ECM) scientific platform provided the opportunity to create a category and educate a multi-stakeholder audience on the key ingredients required to support an actual bioregenerative tissue process. Given the scaffold-like role that an ECM plays within the body, the concept of “Architecting Bioregeneration” took hold and provided the necessary foundational structure.



















